IDKmonitor® Infliximab Total ADA ELISA (Health Canada)
The IDKmonitor® Infliximab Total ADA ELISA (Health Canada) is intended for the determination of human antibodies against TNFα blocker infliximab (e.g. REMICADE®) in the presence
The IDKmonitor® Infliximab Total ADA ELISA (Health Canada) is intended for the determination of human antibodies against TNFα blocker infliximab (e.g. REMICADE®) in the presence
The IDKmonitor® Infliximab Drug Level ELISA (Health Canada) is an enzyme immunoassay intended for the quantitative determination of free therapeutic TNFα antibodies infliximab (e.g., REMICADE®,
The IDKmonitor® Infliximab Free ADA ELISA (Health Canada) is intended to qualitatively determine free human antibodies against Infliximab (e.g., REMICADE®) in EDTA plasma and serum.
The IDKmonitor® Infliximab Free ADA ELISA is intended for the qualitative determination of free human antibodies against Infliximab (e.g. REMICADE®) in EDTA plasma and serum.
The IDKmonitor® Infliximab Total ADA ELISA is intended for the determination of human antibodies against TNF-alpha blocker infliximab (e.g. REMICADE®) in the presence of infliximab
The IDKmonitor® Infliximab Drug Level ELISA is an enzyme immunoassay intended for the quantitative determination of free therapeutic TNFα antibodies infliximab (e.g. REMICADE®, Remsima®, Inflectra®)